My HPRA: Register

Search for a Veterinary Medicine

For centrally authorised product information click here

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie

Veterinary Medicines

Download

Latest list of Authorised or Transfer Pending Products
PDF Version XML Version

Showing 21-40 of 141 matching medicines

Product listings were last updated on 06/08/2020

Order by:

Trade Name	Licence Number & Holder	Documents
Advantage 40 Spot-on solution for Cats 40 mg/pipette Spot-on solution Compare	VPA10021/040/001 Authorised: 23/02/2001 Bayer Limited	SPC
Advantage 40 Spot-on solution for Dogs 40 mg/pipette Spot-on solution Compare	VPA10021/041/001 Authorised: 23/02/2001 Bayer Limited	SPC
Advantage 400 Spot-on solution for Dogs 400 mg/pipette Spot-on solution Compare	VPA10021/042/001 Authorised: 23/02/2001 Bayer Limited	SPC
Advantage 80 mg Spot-on solution for Large Cats and Large Pet Rabbits 80 mg/pipette Spot-on solution Compare	VPA10021/064/002 Authorised: 24/02/2012 Bayer Limited	SPC
Advantage 80 Spot-on solution for Cats 80 mg/pipette Spot-on solution Compare	VPA10021/040/002 Authorised: 23/02/2001 Bayer Limited	SPC
Advantix Spot-on solution for dogs over 10 kg up to 25 kg 250.0/1250.0 mg/pipette Spot-on solution Compare	VPA10021/047/003 Authorised: 02/04/2004 Bayer Limited	SPC
Advantix Spot-on solution for dogs over 25 kg up to 40 kg 400.0/2000.0 mg/pipette Spot-on solution Compare	VPA10021/047/004 Authorised: 02/04/2004 Bayer Limited	SPC
Advantix Spot-on solution for dogs over 4 kg up to 10 kg. 100.0/500.0 mg/pipette Spot-on solution Compare	VPA10021/047/002 Authorised: 02/04/2004 Bayer Limited	SPC
Advantix Spot-on solution for dogs over 40 kg up to 60 kg 600/3000 mg/pipette Spot-on solution Compare	VPA10021/047/005 Authorised: 20/10/2017 Bayer Limited	SPC
Advantix Spot-on solution for dogs up to 4 kg 40.0/200.0 mg/pipette Spot-on solution Compare	VPA10021/047/001 Authorised: 02/04/2004 Bayer Limited	SPC
Agrisept MC Tabs 2.5 g effervescent tablet for teat dip/spray solution 2.5 gram/tablet Tablet Compare	VPA10928/001/001 Authorised: 11/08/2004 Medentech Ltd.	SPC
Alamycin 100 mg/ml Solution for Injection 100 milligram(s)/millilitre Solution for injection Compare	VPA22664/015/001 Authorised: 01/10/1988 Norbrook Laboratories (Ireland) Limited	SPC
Alamycin Aerosol 3.2 %w/v Cutaneous Spray, solution 3.2 percent weight/volume Cutaneous spray, solution Compare	VPA22664/014/001 Authorised: 01/10/1988 Norbrook Laboratories (Ireland) Limited	SPC
Alamycin LA 200 mg/ml Solution for Injection 200 milligram(s)/millilitre Solution for injection Compare	VPA22664/016/001 Authorised: 01/10/1988 Norbrook Laboratories (Ireland) Limited	SPC
Alamycin LA 300 mg/ml Solution for Injection 300 milligram(s)/millilitre Solution for injection Compare	VPA22664/039/001 Authorised: 10/02/1994 Norbrook Laboratories (Ireland) Limited	SPC
Albencare with Selenium Oral Suspension 150 milligram(s)/millilitre Oral suspension Compare	VPA10915/006/001 Authorised: 10/01/1997 Ancare Ireland Ltd.	SPC
Albex 10 % Oral Suspension 10 percent weight/volume Oral suspension Compare	VPA10987/142/002 Authorised: 22/04/1996 Chanelle Pharmaceuticals Manufacturing Limited	SPC
Albex 2.5 % Oral Suspension 2.5 percent weight/volume Oral suspension Compare	VPA10987/142/001 Authorised: 22/04/1996 Chanelle Pharmaceuticals Manufacturing Limited	SPC
Albiotic 330 mg/100 mg Intramammary Solution 330, 100 mg/syringe Intramammary solution Compare	VPA10782/028/001 Authorised: 31/03/2006 Huvepharma NV	SPC
Alcide UDDERgold Platinum 26.4/6.4 milligram(s)/millilitre Teat dip Compare	VPA10795/003/001 Authorised: 30/04/2008 Ecolab Deutschland GmbH	SPC IPAR

Important information regarding cookies and the HPRA

By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy.
For more information on cookies, see our cookie policy.

Click here to accept the cookie policy and hide this message

Date Printed: 06/08/2020